Þorsteinn Loftsson -

Emailthorstlohiis

Research activity per year - in progress

Fingerprint

Dive into the research topics where Þorsteinn Loftsson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

1 Finished

CYCLON HIT: NANOCARRIERS FOR THE DELIVERY OF ANTIMICROBIAL AGENTS TO FIGHT RESISTANCE MECHANISMS
Loftsson, Þ. (PI)
1/03/14 → 28/02/18
Project: Research

299 Article
26 Review article
11 Chapter
3 Editorial
More

A comprehensive nomenclature system for cyclodextrins
Anderson, A. M., O'Connor, M. S., Pipkin, J., Malanga, M., Sohajda, T., Loftsson, T., Szente, L., García-Fandiño, R. & Piñeiro, Á., 15 Jul 2025, In: Carbohydrate Polymers. 360, 123600.
Research output: Contribution to journal › Article › peer-review

Open Access
A look to the future: cyclodextrins and cyclodextrin-based drug delivery to the retina
Jansook, P., Sigurdsson, H. H. & Loftsson, T., 2025, (Accepted/In press) In: Expert Opinion on Drug Delivery.
Research output: Contribution to journal › Review article › peer-review
A recent update of water-soluble polymers in cyclodextrin-based formulations for mucosal drug delivery
Hnin, H. M., Tun, T., Loftsson, T. & Jansook, P., 15 Jun 2025, In: Carbohydrate Polymers. 358, 123539.
Research output: Contribution to journal › Review article › peer-review
Antimicrobial Preservatives in Cyclodextrin-Containing Drug Formulations
Jansook, P., Sigurdsson, H. H., Pilotaz, F. & Loftsson, T., Dec 2024, In: Pharmaceutics. 16, 12, 1601.
Research output: Contribution to journal › Review article › peer-review

Open Access
Aqueous eye drop formulations: Cyclodextrins as enabling excipients
Pilotaz, F. & Loftsson, T., Nov 2024, In: Annales Pharmaceutiques Francaises. 82, 6, p. 994-1007 14 p.
Research output: Contribution to journal › Review article › peer-review

Oculis Raises USD57 Million in Series C Financing
Þorsteinn Loftsson
5/05/21
1 item of Media coverage
Press/Media
Australia Patent: Application for 'Formation of cyclosporin A/cyclodextrin nanoparticles' Lapses
Þorsteinn Loftsson
18/01/20
1 item of Media coverage
Press/Media
WIPO PUBLISHES PATENT OF OCULIS EHF FOR "PREPARATION OF SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY" (ICELANDER INVENTORS)
Þorsteinn Loftsson
14/06/18
1 item of Media coverage
Press/Media
Oculis raises CHF20M series B
Þorsteinn Loftsson
4/01/18
2 items of Media coverage
Press/Media
Australia Patent: Oculis ehf. Files Application for 'Formation of cyclosporin A/cyclodextrin nanoparticles'
Þorsteinn Loftsson
16/12/17
1 item of Media coverage
Press/Media

Loftsson Þorsteinn

Fingerprint

Collaborations and top research areas from the last five years

Dive into details

CYCLON HIT: NANOCARRIERS FOR THE DELIVERY OF ANTIMICROBIAL AGENTS TO FIGHT RESISTANCE MECHANISMS

A comprehensive nomenclature system for cyclodextrins

A look to the future: cyclodextrins and cyclodextrin-based drug delivery to the retina

A recent update of water-soluble polymers in cyclodextrin-based formulations for mucosal drug delivery

Antimicrobial Preservatives in Cyclodextrin-Containing Drug Formulations

Aqueous eye drop formulations: Cyclodextrins as enabling excipients

Oculis Raises USD57 Million in Series C Financing

Australia Patent: Application for 'Formation of cyclosporin A/cyclodextrin nanoparticles' Lapses

WIPO PUBLISHES PATENT OF OCULIS EHF FOR "PREPARATION OF SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY" (ICELANDER INVENTORS)

Oculis raises CHF20M series B

Australia Patent: Oculis ehf. Files Application for 'Formation of cyclosporin A/cyclodextrin nanoparticles'

Loftsson Þorsteinn

Fingerprint

Collaborations and top research areas from the last five years

Projects

Research output

Press/Media